Ci Investments Inc. Gilead Sciences, Inc. Transaction History

Ci Investments Inc.

$26.3 Billion
Q3 2024

A detailed history of Ci Investments Inc. transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Ci Investments Inc. holds 118,991 shares of GILD stock, worth $10.9 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

118,991

Previous 125,525 5.21%

Holding current value

$10.9 Million

Previous $8.61 Million 15.84%

% of portfolio

0.04%

Previous 0.03%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$66.59 - $83.99 $435,099 - $548,790	-6,534 Reduced 5.21%	118,991 $9.98 Million
Q2 2024 Aug 12, 2024	SELL	$63.15 - $72.88 $158,064 - $182,418	-2,503 Reduced 1.96%	125,525 $8.61 Million
Q1 2024 May 13, 2024	BUY	$71.58 - $87.29 $2.03 Million - $2.48 Million	28,418 Added 28.53%	128,028 $9.38 Million
Q4 2023 Feb 12, 2024	BUY	$73.27 - $83.09 $1.86 Million - $2.11 Million	25,361 Added 34.16%	99,610 $8.07 Million
Q3 2023 Nov 13, 2023	SELL	$73.94 - $80.67 $708,271 - $772,737	-9,579 Reduced 11.43%	74,249 $5.56 Million
Q2 2023 Aug 11, 2023	SELL	$76.01 - $86.7 $653,229 - $745,099	-8,594 Reduced 9.3%	83,828 $6.46 Million
Q1 2023 May 12, 2023	BUY	$77.31 - $88.08 $3.33 Million - $3.79 Million	43,042 Added 87.16%	92,422 $7.67 Million
Q4 2022 Feb 10, 2023	BUY	$62.32 - $89.47 $252,271 - $362,174	4,048 Added 8.93%	49,380 $4.24 Million
Q3 2022 Nov 14, 2022	BUY	$59.54 - $68.01 $11,550 - $13,193	194 Added 0.43%	45,332 $2.8 Million
Q2 2022 Aug 12, 2022	SELL	$57.72 - $65.01 $140,605 - $158,364	-2,436 Reduced 5.12%	45,138 $2.79 Million
Q1 2022 May 12, 2022	BUY	$57.92 - $72.58 $727,822 - $912,040	12,566 Added 35.89%	47,574 $2.83 Million
Q4 2021 Feb 11, 2022	BUY	$64.88 - $73.64 $441,248 - $500,825	6,801 Added 24.11%	35,008 $2.54 Million
Q3 2021 Nov 12, 2021	SELL	$67.69 - $73.03 $3.17 Million - $3.42 Million	-46,856 Reduced 62.42%	28,207 $1.97 Million
Q2 2021 Aug 13, 2021	SELL	$63.47 - $69.35 $1.61 Million - $1.76 Million	-25,329 Reduced 25.23%	75,063 $5.17 Million
Q1 2021 May 13, 2021	SELL	$60.0 - $68.46 $16.9 Million - $19.3 Million	-282,029 Reduced 73.75%	100,392 $6.49 Million
Q4 2020 Feb 09, 2021	BUY	$56.65 - $64.55 $261,156 - $297,575	4,610 Added 1.22%	382,421 $22.3 Million
Q3 2020 Nov 09, 2020	BUY	$62.1 - $78.08 $1.91 Million - $2.4 Million	30,712 Added 8.85%	377,811 $23.9 Million
Q2 2020 Aug 07, 2020	SELL	$72.34 - $84.0 $63.4 Million - $73.6 Million	-876,035 Reduced 71.62%	347,099 $26.7 Million
Q1 2020 Aug 07, 2020	SELL	$62.63 - $80.22 $280 Million - $359 Million	-4,469,319 Reduced 78.51%	1,223,134 $91.4 Million
Q4 2019 Feb 11, 2020	SELL	$61.62 - $67.78 $57.5 Million - $63.2 Million	-932,593 Reduced 14.08%	5,692,453 $370 Million
Q3 2019 Nov 08, 2019	BUY	$62.51 - $69.0 $57.4 Million - $63.3 Million	917,751 Added 16.08%	6,625,046 $420 Million
Q2 2019 Aug 12, 2019	BUY	$61.87 - $69.38 $50.4 Million - $56.6 Million	815,359 Added 16.67%	5,707,295 $387 Million
Q1 2019 May 15, 2019	SELL	$62.53 - $70.05 $38.3 Million - $42.9 Million	-611,943 Reduced 11.12%	4,891,936 $318 Million
Q4 2018 Feb 15, 2019	BUY	$60.54 - $79.0 $241 Million - $315 Million	3,987,484 Added 262.96%	5,503,879 $344 Million
Q3 2018 Nov 09, 2018	BUY	$71.28 - $78.92 $20.1 Million - $22.3 Million	282,342 Added 22.88%	1,516,395 $117 Million
Q2 2018 Aug 14, 2018	BUY	$64.88 - $75.68 $34.1 Million - $39.8 Million	526,174 Added 74.33%	1,234,053 $87.4 Million
Q1 2018 May 14, 2018	SELL	$72.84 - $88.8 $78.1 Million - $95.2 Million	-1,072,613 Reduced 60.24%	707,879 $53.4 Million
Q4 2017 May 14, 2018	SELL	$71.15 - $83.52 $25.7 Million - $30.1 Million	-360,560 Reduced 16.84%	1,780,492 $128 Million
Q4 2017 Feb 02, 2018	BUY	$71.15 - $83.52 $106 Million - $124 Million	1,483,427 Added 225.57%	2,141,052 $153 Million
Q3 2017 Nov 06, 2017	BUY	$72.11 - $85.47 $47.4 Million - $56.2 Million	657,625	657,625 $53.3 Million

Others Institutions Holding GILD

# of Institutions

1,927

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $114B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ci Investments Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ci Investments Inc. with notifications on news.

Account

Ci Investments Inc. Gilead Sciences, Inc. Transaction History